Cell of Origin Combined With CNS International Prognostic Index Improves Identification of DLBCL Patients With High CNS Relapse Risk After Initial Immunochemotherapy
Hematological Oncology - United Kingdom
doi 10.1002/hon.2437_25
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2017
Authors
Publisher
Wiley